US Bancorp’s Alaunos Therapeutics TCRT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-93
| Closed | -$9K | – | 4227 |
|
|
2022
Q1 | $9K | Buy |
93
+30
| +48% | +$3.85K | ﹤0.01% | 3422 |
|
|
2021
Q4 | $10K | Buy |
63
+37
| +142% | +$8.13K | ﹤0.01% | 3433 |
|
|
2021
Q3 | $7K | Buy |
26
+16
| +160% | +$4.89K | ﹤0.01% | 3563 |
|
|
2021
Q2 | $4K | Buy |
+10
| New | +$4.67K | ﹤0.01% | 3680 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 3961 |
|
|
2020
Q3 | – | Sell |
-3
| Closed | -$2K | – | 3841 |
|
|
2020
Q2 | $2K | Hold |
3
| – | – | ﹤0.01% | 3533 |
|
|
2020
Q1 | $1K | Hold |
3
| – | – | ﹤0.01% | 3606 |
|
|
2019
Q4 | $2K | Hold |
3
| – | – | ﹤0.01% | 3503 |
|
|
2019
Q3 | $2K | Hold |
3
| – | – | ﹤0.01% | 3440 |
|
|
2019
Q2 | $3K | Buy |
+3
| New | +$2.06K | ﹤0.01% | 3403 |
|
|
2018
Q4 | – | Sell |
-73
| Closed | -$35K | – | 3686 |
|
|
2018
Q3 | $35K | Hold |
73
| – | – | ﹤0.01% | 2729 |
|
|
2018
Q2 | $33K | Hold |
73
| – | – | ﹤0.01% | 2755 |
|
|
2018
Q1 | $43K | Hold |
73
| – | – | ﹤0.01% | 2687 |
|
|
2017
Q4 | $46K | Hold |
73
| – | – | ﹤0.01% | 2634 |
|
|
2017
Q3 | $68K | Hold |
73
| – | – | ﹤0.01% | 2427 |
|
|
2017
Q2 | $68K | Hold |
73
| – | – | ﹤0.01% | 2394 |
|
|
2017
Q1 | $70K | Hold |
73
| – | – | ﹤0.01% | 2315 |
|
|
2016
Q4 | $59K | Hold |
73
| – | – | ﹤0.01% | 2359 |
|
|
2016
Q3 | $62K | Hold |
73
| – | – | ﹤0.01% | 2335 |
|
|
2016
Q2 | $60K | Hold |
73
| – | – | ﹤0.01% | 2316 |
|
|
2016
Q1 | $82K | Hold |
73
| – | – | ﹤0.01% | 2128 |
|
|
2015
Q4 | $91K | Hold |
73
| – | – | ﹤0.01% | 2130 |
|
|
2015
Q3 | $99K | Hold |
73
| – | – | ﹤0.01% | 2086 |
|
|
2015
Q2 | $132K | Hold |
73
| – | – | ﹤0.01% | 1977 |
|
|
2015
Q1 | $118K | Hold |
73
| – | – | ﹤0.01% | 2065 |
|
|
2014
Q4 | $56K | Hold |
73
| – | – | ﹤0.01% | 2466 |
|
|
2014
Q3 | $29K | Hold |
73
| – | – | ﹤0.01% | 2718 |
|
|
2014
Q2 | $44K | Hold |
73
| – | – | ﹤0.01% | 2554 |
|
|
2014
Q1 | $50K | Hold |
73
| – | – | ﹤0.01% | 2472 |
|
|
2013
Q4 | $48K | Hold |
73
| – | – | ﹤0.01% | 2433 |
|
|
2013
Q3 | $43K | Hold |
73
| – | – | ﹤0.01% | 2395 |
|
|
2013
Q2 | $23K | Buy |
+73
| New | +$20.3K | ﹤0.01% | 2603 |
|
Other funds holding TCRT
MP
DCM
LCM
US Bancorp's TCRT Position: Q2 2022 in Review
US Bancorp sold out of Alaunos Therapeutics (TCRT) in Q2 2022, closing a stake of 93 shares — an estimated $9K sold.
US Bancorp first reported a position in TCRT in Q2 2013 and held it in 31 quarters. The position peaked at $132K in Q2 2015. 124 funds tracked by Wall St. Rank hold TCRT as of Q2 2022.
- US Bancorp reported no remaining Alaunos Therapeutics position as of Q2 2022 after selling out during the quarter.
- US Bancorp sold 93 Alaunos Therapeutics shares in Q2 2022, an estimated $9K.
- US Bancorp first reported a position in Alaunos Therapeutics in Q2 2013 and held it in 31 quarters.
- US Bancorp's Alaunos Therapeutics position peaked at $132K in Q2 2015.
- 124 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q2 2022.
Based on US Bancorp's 13F filing for Q2 2022, filed 1 Aug 2022.